Editorial: Development/repurposing of drugs to tackle the multiple variants of SARS-CoV-2
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Livro |
| Publicado em: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
| Assuntos: | |
| Acesso em linha: | Connect to this object online. |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_62b569a2a00d4b9cae60c0a4a0e404c5 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Dinorah Gambino |e author |
| 245 | 0 | 0 | |a Editorial: Development/repurposing of drugs to tackle the multiple variants of SARS-CoV-2 |
| 260 | |b Frontiers Media S.A., |c 2023-02-01T00:00:00Z. | ||
| 500 | |a 2674-0338 | ||
| 500 | |a 10.3389/fddsv.2023.1157688 | ||
| 546 | |a EN | ||
| 690 | |a COVID-19 | ||
| 690 | |a SARS-CoV-2 | ||
| 690 | |a repurposing of drugs post‐COVID‐19 | ||
| 690 | |a clinical trials | ||
| 690 | |a new antiviral drugs | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Drug Discovery, Vol 3 (2023) | |
| 787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fddsv.2023.1157688/full | |
| 787 | 0 | |n https://doaj.org/toc/2674-0338 | |
| 856 | 4 | 1 | |u https://doaj.org/article/62b569a2a00d4b9cae60c0a4a0e404c5 |z Connect to this object online. |